Scientific News Semler Scientific Great Product Can Still Thrive Post Medicare Advantage
Search Related Content
Sorry, Your Requested Page Was Not Found. Greetings! We apologize for the inconvenience, but the page, Scientific News Semler Scientific Great Product Can Still Thrive Post Medicare Advantage is no longer available. Please use our search box below to find related content and browse the list of related news stories. Depending on the topic, news articles are deleted 3-18 months after their creation date. We prefer to keep content fresh and current, rather than holding onto outdated news. Thanks for visiting today.Search RobinsPost News & Noticias
Semler Scientific’s Stockholder Meeting Approves Key Proposals
Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence. An announcement from Semler Scientific ( ... Read More
Semler Scientific targets 10,000 Bitcoin by year-end 2025 while expanding CardioVanta health business
Management maintained their Bitcoin accumulation targets of 10,000 by year-end 2025, 42,000 by year-end 2026, and 105,000 by year-end 2027. The company is actively exploring various financing options, ... Read More
DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Semler Scientific
Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Semler Scientific, Inc. (“Semler Scientific” or the “Company”) (NASDAQ: SMLR) and reminds ... Read More
Bitcoin Treasury Firm Semler Scientific Still Has 3X Upside: Benchmark
Semler Scientific (SMLR) is trading just above the market value of its bitcoin holdings, with a market NAV (mNAV) of 1.04, highlighting what broker Benchmark calls a significant valuation disconnect. Read More
SMLR Investor News: If You Have Suffered Losses in Semler Scientific, Inc. (NASDAQ: SMLR), You Are Encouraged to Contact The Rosen Law Firm About Your Rights
WHY: Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of Semler Scientific, Inc. (NASDAQ: SMLR) resulting from ... Read More
SHAREHOLDER ACTION REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Semler Scientific
NEW YORK, Oct. 2, 2025 /PRNewswire/ -- Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Semler Scientific, Inc. ("Semler Scientific" or the ... Read More
Semler Scientific, Inc. (NASDAQ:SMLR) Q2 2025 Earnings Call Transcript
Semler Scientific, Inc. beats earnings expectations. Reported EPS is $5.04, expectations were $-0.1. Operator: Please go ahead, sir. Joe Burnett: Good afternoon, and welcome to the Semler Scientific ... Read More
Blow Us A Whistle
Comments (Whistles) Designed By Disqus